DAVITA INC shareholders Q4 2021

DAVITA INC's ticker is DVA and the CUSIP is 23918K108. A total of 493 filers reported holding DAVITA INC in Q4 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

DAVITA INC shareholders Q4 2021
Name	Shares	Value	Weighting ↓
DPM Capital LLC	691,426	$78,657,000	100.00%
Iron Triangle Partners LP	450,000	$51,192,000	7.13%
Gates Capital Management	1,601,450	$182,181,000	5.04%
SPEECE THORSON CAPITAL GROUP INC	186,774	$21,247,000	4.06%
ROVIN CAPITAL /UT/ /ADV	52,203	$5,939,000	2.85%
L2 Asset Management, LLC	22,584	$2,569,000	1.79%
Glenview Capital Management	532,638	$60,593,000	1.29%
Berkshire Hathaway	36,095,570	$4,106,232,000	1.24%
Kent Lake Capital LLC	20,000	$2,275,000	1.18%
Inlet Private Wealth, LLC	42,155	$4,796,000	1.16%
Factorial Partners, LLC	15,000	$1,706,000	1.13%
TODD ASSET MANAGEMENT LLC	456,688	$51,953,000	1.12%
Aurora Investment Counsel	16,313	$1,856,000	1.10%
SHEPHERD KAPLAN KROCHUK, LLC	25,400	$2,890,000	1.04%
Te Ahumairangi Investment Management Ltd	61,644	$7,013,000	0.91%
Martin Capital Advisors, LLP	11,582	$1,318,000	0.82%
Sippican Capital Advisors	8,265	$940,000	0.80%
HELIOS CAPITAL MANAGEMENT PTE. LTD	7,600	$865,000	0.78%
Venturi Wealth Management, LLC	82,892	$9,430,000	0.71%
Curated Wealth Partners LLC	18,535	$2,109,000	0.68%

About DAVITA INC

DaVita Inc. is a leading provider of kidney care services in the United States. The company operates more than 2,700 dialysis clinics across the country, serving approximately 203,000 patients. DaVita's mission is to improve the quality of life for those living with kidney disease, and the company is committed to providing high-quality, compassionate care to its patients.

DaVita's success can be attributed to its focus on patient-centered care. The company's care teams work closely with patients to develop personalized treatment plans that meet their unique needs. DaVita also invests heavily in technology and innovation to improve patient outcomes and enhance the overall patient experience.

In addition to its core kidney care services, DaVita also operates a number of strategic business units, including DaVita Kidney Care, DaVita Medical Group, and DaVita International. These units allow the company to diversify its revenue streams and expand its reach into new markets.

Despite its success, DaVita faces a number of challenges in the highly competitive healthcare industry. The company must navigate complex regulatory environments, manage rising healthcare costs, and adapt to changing patient needs and preferences.

Overall, DaVita is a strong player in the kidney care market, with a proven track record of delivering high-quality care to its patients. As the healthcare industry continues to evolve, DaVita will need to remain agile and innovative to stay ahead of the curve.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists DAVITA INC's shareholders in Q4 2021. To view DAVITA INC's shareholder history, click here.